Clinical Trial Update: The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG [NA]

View source ↗

Summary

This clinical trial update explores the potential role of Gallium-68 PSMA PET imaging for staging, restaging, and monitoring response in hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Ga-68 PSMA (Gallium-68 PSMA-11)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: UNKNOWN